- Depression
- Submitted on 31/03/2025
Αλλαγή από Σεροπράμ σε Εφεξόρ: Ευαισθησία και Κλάμα Φυσιολογικά;
Έκανα αγωγή 4 χρονια με σεροπραμ άλλαξα αγωγή απότομα σε εφεξορ μετά από 15 μέρες με εφεξορ νοιώθω ευάλωτη και μιυ βγαίνει μια ευαίσθητο και κλαιω είναι φυσικά?ακόμη το εφεξορ δεν έχει κάνει επίπεδα?έφυγε το σεροπραμ απ τον οργανισμό και είναι εν μέρη ακάλυπτο?
1 specialist answered
-
Μιλήστε με τον ψυχίατρο σας που ξέρει το ιστορικό σας να σας κατευθύνει, είναι πιθανόν αυτό που υποψιάζεστε.
The content of the answers is strictly informative and should not be considered a substitute for medical advice
Ask our specialists
Get answers to your health concerns. Submit your question anonymously and our specialists will help.
We’ll email you when a specialist replies.
An unexpected error occurred but we’re working on it. Please try again.
-
Do
Provide details about your health concerns
Be short and to the point so specialists can give you a clear answer
-
Don’t
Refer to people by name
Request price for services
Post offensive or abusive content
Request pharmaceutical products recommendations or any medical prescription
Submit an anonymous question
We moderate your questions and send them to doctoranytime specialists
Get updates for your question
If you enter your email, we’ll notify you when a specialist answers your question
Check the answers
Once your question receives an answer, we’ll post it in the related doctoranytime sections
Do you need to see a health expert right away?
Start a Video Consultation with a health specialist within 5 minutes
We have received your question!
We’ll send you an email when a specialist responds.
No time to wait? Get immediate answers from a General Practitioners/Internists via chat!
Subscribe our Instant Care plan to access unlimited chat consultations and address your medical needs instantly.
Looking for personalized advice on medication?
“Ask our specialists” doctors provide general advice. For specific guidance, tailored to your individual needs, we recommend using our chat service.